Did you know this version of Internet Explorer is out of date?

To get the latest experience from our website, please upgrade your browser.

Have a drug or medical device concern?



Sort By
Drugwatch.com Author

Chris ElkinsStaff Writer

Chris Elkins is a writer and researcher for Drugwatch.com. He’s worked for various newspapers and has writing experience in sports, health communication and public relations fields. He graduated from the University of West Florida with a master’s degree in Strategic Communication and Leadership, a graduate-level certificate in Health Communication Leadership and a bachelor’s degree in Journalism.

Chris is a writer and researcher for DrugWatch. With a background in health communication, he has a passion for patient’s rights and hopes to contribute to the improvement of the way the healthcare industry operates and communicates.

With a passion for sports and writing, he began his career as a sportswriter while attending the University of West Florida. He landed his first job as a contributing writer for the campus newspaper, The Voyager, and as a freelancer for the Pensacola News Journal. He went on to freelance for a variety of publications and land roles as the Sports Editor at The Voyager and as an intern at the PNJ.

After graduating with a bachelor’s degree in journalism, Chris switched to public relations. He worked for the UWF Athletic Communications department, promoting the university’s athletics teams while attending graduate school. During that time he worked on a number of communications projects for organizations in the community, exposing him to health communication for the first time and giving him experience with nonprofit organizations and university administration. He was later offered a role as a research fellow working with Dr. Athena du Pre, researching and writing for her textbook Communicating About Health: Current Issues and Perspectives.

He’s an avid runner, passionate movie critic and enthusiastic baseball fan.

Close-up of diabetes pen

FDA Adds Ketoacidosis, UTI Warnings to Invokana & SGLT2 Inhibitor Labels

The U.S. Food and Drug Administration ordered makers of sodium-glucose cotransporter-2 (SGLT2) inhibitors to add warnings of risks for ketoacidosis and urinary tract infections to the drugs’ labels. The...

Kentucky Capitol building

Kentucky Takes Purdue Pharma to Court over OxyContin Addiction

The state of Kentucky is continuing to fight OxyContin manufacturer Purdue Pharma in state court. In a legal drama that’s moved back and forth between state and federal courts and involved multiple...

doctors performing surgery on a patient

Study: Inferior Vena Cava (IVC) Filters Don’t Help Trauma Patients

People who suffer traumatic injuries face a “life-threatening” risk for blood clots, but inferior vena cava (IVC) filters don’t give them a survival benefit, according to a new study. ...

Medical endoscopy tools

FDA Recalls Cleaning Machines after Scopes Linked to Infections

The U.S. Food and Drug Administration ordered a recall of machines used to clean medical scopes linked to superbug infections. Custom Ultrasonics must recall about 2,800 machines used to clean...

Gloved hand sprays Weed Killer

Weed-Killer Roundup ‘Probably’ Causes Cancer

The World Health Organization is declaring the main ingredient in Monsanto’s weed killer Roundup “probably” causes cancer. After decades of debate, reversed decisions and protests,...

Older woman with chest pain

Daughter Claims Diabetes Drug Onglyza Caused Mom’s Heart Failure

The daughter of a woman who suffered heart failure after taking Onglyza (saxagliptin) claims the diabetes drug contributed to her mother’s death. In the lawsuit filed against drugmaker AstraZeneca,...

Page 1 Page 2 Page 5
Free Invokana Case Review